This HTML5 document contains 30 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q58407884
rdf:type
wikibase:Item
schema:description
klinisch onderzoek A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
rdfs:label
Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases (DENIVOS) Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases (DENIVOS)
skos:prefLabel
Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases (DENIVOS) Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases (DENIVOS) Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases
schema:name
Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases (DENIVOS) Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases (DENIVOS)
p:P31
wds:Q58407884-98E3311B-3EA6-44E5-93AB-95F5C5D86BC1
wdt:P31
wd:Q30612
p:P921
wds:Q58407884-71CF1F87-A66B-47CE-9747-E58EB505BD9A
wdt:P921
wd:Q2012719
p:P6153
wds:Q58407884-EF082CB4-EBD0-4CB1-A12A-6AEF96317597 wds:Q58407884-74194D01-EA78-4CDF-86BF-5E2BAC120D06
wdt:P6153
wd:Q2945753 wd:Q50036396
p:P2899
wds:Q58407884-3A16D7AE-0371-45E9-B793-266F6D8D443E
wdt:P2899
18
p:P1050
wds:Q58407884-E3A108FD-39AC-4E40-AEB2-C302AF3C27DD wds:Q58407884-7AC33A46-CD31-4174-B01F-B2ADC06619B9
wdt:P1050
wd:Q181876 wd:Q1328805
p:P8363
wds:Q58407884-01BA9DD1-78E7-4A47-8D26-23E0792F7497
wdt:P8363
wd:Q78089383
p:P3098
wds:Q58407884-8AE069B9-3A2D-431C-9D85-1BF8CCBD3394
wdt:P3098
NCT03669523